Biofil Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and approve To consider ....
BIOFILCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Biofil Chemicals & Pharmaceuticals has informed the exchanges that its Board of Directors will meet on Thursday, 13th November 2025 at the registered office in Indore. The main agenda item is to consider and approve the Un-Audited Financial Results for the quarter and half year ended 30th September 2025, along with the Limited Review Report from auditors. Other routine business matters may also be discussed with the Chair's permission. The company has also informed that the trading window for insiders will reopen 48 hours after the results are declared.
Routine regulatory intimation ahead of quarterly results. Investors should watch for the Q2/H1 FY26 earnings announcement on or after 13th November, which may move the stock based on the actual numbers reported. No immediate price impact expected from the meeting notice itself.